Literature DB >> 20646840

Defining radiotherapy target volumes using 18F-fluoro-deoxy-glucose positron emission tomography/computed tomography: still a Pandora's box?

Slobodan Devic1, Nada Tomic, Sergio Faria, Sonia Menard, Robert Lisbona, Shirley Lehnert.   

Abstract

PURPOSE: We discuss the effect of (18)F-fluoro-deoxy-glucose (FDG) positron emission tomography (PET)/computed tomography (CT) data on target volume definition for radiotherapy planning. We compared the effect of various thresholding methods on the PET-based target volume vs. the standard CT-based tumor volume. METHODS AND MATERIALS: Different thresholding methods were reviewed and compared to our PET-based gross tumor volume data obtained from a cohort of 31 non-small-cell lung carcinoma patients who had undergone preoperative PET/CT scans for staging. The feasibility and limitations of FDG-based PET/CT data on target volume delineation in radiotherapy planning have been demonstrated with frequently used approaches for target outlining such as the qualitative visual method and the fixed 15% or 40% of the maximal iso-uptake value threshold methods.
RESULTS: The relationship between PET-based and CT-based volumes generally suffers from poor correlation between the two image data sets, expressed in terms of a large statistical variation in gross tumor volume ratios, irrespective of the threshold method used. However, we found that the maximal signal/background ratios in non-small-cell lung carcinoma patients correlated well with the pathologic results, with an average ratio for adenocarcinoma, large cell carcinoma, and squamous cell carcinoma of 10.5 ± 3.5, 12.6 ± 2.8, and 14.1 ± 5.9, respectively.
CONCLUSION: The fluctuations in tumor volume using different quantitative PET thresholding approaches did not depend on the thresholding method used. They originated from the nature of functional imaging in general and PET imaging in particular. Functional imaging will eventually be used for biologically tailored target radiotherapy volume definition not as a replacement of CT- or magnetic resonance imaging-based anatomic gross tumor volumes but with the methods complementing each other in a complex mosaic of distinct biologic target volumes.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20646840     DOI: 10.1016/j.ijrobp.2010.02.015

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  12 in total

1.  Mechanisms of blood flow and hypoxia production in rat 9L-epigastric tumors.

Authors:  Cameron J Koch; W Timothy Jenkins; Kevin W Jenkins; Xiang Yang Yang; A Lee Shuman; Stephen Pickup; Caitlyn R Riehl; Ramesh Paudyal; Harish Poptani; Sydney M Evans
Journal:  Tumor Microenviron Ther       Date:  2013-01

2.  Metabolic Tumor Volume on PET Reduced More than Gross Tumor Volume on CT during Radiotherapy in Patients with Non-Small Cell Lung Cancer Treated with 3DCRT or SBRT.

Authors:  Pawinee Mahasittiwat; Shuanghu Yuan; Congying Xie; Timothy Ritter; Yue Cao; Randall K Ten Haken; Feng-Ming Spring Kong
Journal:  J Radiat Oncol       Date:  2013-06

3.  Tumor volume as a predictor of survival in human papillomavirus-positive oropharyngeal cancer.

Authors:  Kara S Davis; Chwee Ming Lim; David A Clump; Dwight E Heron; James P Ohr; Seungwon Kim; Umamaheswar Duvvuri; Jonas T Johnson; Robert L Ferris
Journal:  Head Neck       Date:  2015-12-17       Impact factor: 3.147

4.  Correlation between 18F-FDG PET/CT intra-tumor metabolic heterogeneity parameters and KRAS mutation in colorectal cancer.

Authors:  Xin Liu; Shi-Cun Wang; Ming Ni; Qiang Xie; Yi-Fan Zhang; Wei-Fu Lv; Guang-Yong Geng
Journal:  Abdom Radiol (NY)       Date:  2022-02-09

5.  Use of FDG-PET in Radiation Treatment Planning for Thoracic Cancers.

Authors:  Katsuyuki Shirai; Akiko Nakagawa; Takanori Abe; Masahiro Kawahara; Jun-Ichi Saitoh; Tatsuya Ohno; Takashi Nakano
Journal:  Int J Mol Imaging       Date:  2012-05-14

6.  Variability of Gross Tumor Volume in Nasopharyngeal Carcinoma Using 11C-Choline and 18F-FDG PET/CT.

Authors:  Jun Jiang; Hubing Wu; Meiyan Huang; Yao Wu; Quanshi Wang; Jianqi Zhao; Wei Yang; Wufan Chen; Qianjin Feng
Journal:  PLoS One       Date:  2015-07-10       Impact factor: 3.240

Review 7.  The utility of positron emission tomography in the treatment planning of image-guided radiotherapy for non-small cell lung cancer.

Authors:  Alexander Chi; Nam P Nguyen
Journal:  Front Oncol       Date:  2014-10-07       Impact factor: 6.244

Review 8.  The role of PET-CT in radiotherapy planning of solid tumours.

Authors:  Stasa Jelercic; Mirjana Rajer
Journal:  Radiol Oncol       Date:  2015-03-03       Impact factor: 2.991

9.  Evaluation of Hybrid PET/MRI for Gross Tumor Volume (GTV) Delineation in Colorectal Cancer Liver Metastases Radiotherapy.

Authors:  Yan-Nan Zhang; Xin Lu; Zhen-Guo Lu; Li-Ping Fu; Jun Zhao; Zuo-Lin Xiang
Journal:  Cancer Manag Res       Date:  2021-07-06       Impact factor: 3.989

10.  Efficacy of FDG-PET for defining gross tumor volume of head and neck cancer.

Authors:  Chikae Kajitani; Isao Asakawa; Fumiaki Uto; Emiko Katayama; Kazuya Inoue; Tetsuro Tamamoto; Norihisa Shirone; Hideyuki Okamoto; Tadaaki Kirita; Masatoshi Hasegawa
Journal:  J Radiat Res       Date:  2013-01-03       Impact factor: 2.724

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.